tiprankstipranks
Trending News
More News >
Advertisement

ARKK - ETF AI Analysis

Compare

Top Page

ARKK

Ark Innovation Etf (ARKK)

Rating:58Neutral
Price Target:
ARKK, the Ark Innovation ETF, has a mixed but generally positive rating driven by innovative growth names like Tesla and AMD, which benefit from strong financial performance, upbeat earnings calls, and solid growth prospects. Coinbase, Robinhood, Circle, and Roku also support the fund’s quality through improving fundamentals and strategic initiatives, though many face valuation, technical, or profitability challenges. Weaker holdings such as Crispr Therapeutics and Roblox, with financial and profitability issues and bearish technical signals, along with the fund’s concentration in a small group of high-growth, tech-focused names, add risk and help explain why the rating is not higher.
Positive Factors
Focused Innovation Theme
The fund targets innovative companies in areas like technology and health care, offering exposure to high-growth themes that many broad market funds miss.
Sector Diversification Within Growth Areas
Holdings are spread across several growth-oriented sectors such as health care, technology, consumer cyclical, and financials, which helps avoid relying on just one industry.
Large Asset Base
The ETF manages a sizable pool of assets, which can support trading liquidity and make it easier for investors to enter and exit positions.
Negative Factors
High Expense Ratio
The fund charges relatively high annual fees compared with many ETFs, which can eat into long-term returns.
Concentrated Top Holdings
A small number of stocks like Tesla and other large positions make up a significant share of the portfolio, increasing the impact if any of them perform poorly.
Recent Performance Weakness
The ETF has shown weak short-term performance, with several top holdings such as Tesla, Roku, Shopify, Robinhood, and Palantir lagging so far this year.

ARKK vs. SPDR S&P 500 ETF (SPY)

ARKK Summary

ARKK is an exchange-traded fund that focuses on “disruptive innovation” rather than tracking a traditional index. It is actively managed and invests in U.S. companies working on new technologies in areas like artificial intelligence, robotics, genetics, and digital finance. Well-known holdings include Tesla and AMD, along with firms in biotech and online platforms. Someone might invest in ARKK if they want growth potential from cutting-edge tech and health care companies in a single, diversified fund. A key risk is that these innovative stocks can be very volatile, so the ETF’s price can rise and fall sharply.
How much will it cost me?The Ark Innovation ETF (ARKK) has an expense ratio of 0.75%, which means you’ll pay $7.50 per year for every $1,000 invested. This is higher than average because the fund is actively managed, meaning experts are constantly adjusting its holdings to focus on innovative and disruptive companies.
What would affect this ETF?The Ark Innovation ETF (ARKK) could benefit from continued advancements in technology and innovation, particularly in areas like artificial intelligence, robotics, and genomics, which are key focuses of its portfolio. However, it may face challenges from rising interest rates, which can negatively impact growth-focused investments, and regulatory changes in sectors like fintech or healthcare. Global economic uncertainty could also affect the performance of its top holdings, such as Tesla and Coinbase, which are sensitive to market conditions.

ARKK Top 10 Holdings

ARKK is leaning hard into disruptive growth, but its biggest bets are currently hitting some turbulence. Tesla, the fund’s flagship holding, has been choppy—occasionally perking up but generally losing steam this year. High‑octane fintech and crypto plays like Robinhood and Coinbase are clearly dragging the fund, with both stocks under pressure in recent months. On the brighter side, gene-editing names such as Crispr and Beam have shown more mixed but occasionally rising momentum. Overall, ARKK is a globally focused, innovation-heavy portfolio, with notable concentration in U.S. tech, fintech, and biotech names.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Tesla10.16%$671.77M$1.50T79.46%
73
Outperform
Crispr Therapeutics AG6.65%$439.98M$5.64B35.62%
40
Underperform
Tempus AI, Inc. Class A5.05%$333.99M$9.31B15.83%
52
Neutral
Shopify4.92%$325.11M$174.03B43.94%
Circle Internet Group, Inc. Class A4.71%$311.41M$26.30B
64
Neutral
Coinbase Global4.59%$303.65M$52.76B11.47%
68
Neutral
Robinhood4.45%$294.30M$71.44B122.70%
68
Neutral
Roku4.09%$270.19M$14.77B40.79%
65
Neutral
Advanced Micro Devices3.73%$246.71M$330.45B109.75%
73
Outperform
Beam Therapeutics3.60%$237.76M$2.81B7.51%
58
Neutral

ARKK Technical Analysis

Technical Analysis Sentiment
Negative
Last Price
Price Trends
50DMA
75.90
Negative
100DMA
78.93
Negative
200DMA
76.51
Negative
Market Momentum
MACD
-0.42
Negative
RSI
48.10
Neutral
STOCH
56.94
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ARKK, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 72.27, equal to the 50-day MA of 75.90, and equal to the 200-day MA of 76.51, indicating a neutral trend. The MACD of -0.42 indicates Negative momentum. The RSI at 48.10 is Neutral, neither overbought nor oversold. The STOCH value of 56.94 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ARKK.

ARKK Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$6.45B0.75%
58
Neutral
$8.79B0.55%
60
Neutral
$1.98B0.75%
67
Neutral
$1.66B0.76%
58
Neutral
$1.63B0.65%
61
Neutral
$1.14B0.75%
53
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ARKK
Ark Innovation Etf
72.89
24.70
51.26%
BAI
iShares A.I. Innovation and Tech Active ETF
ARKQ
ARK Autonomous Technology & Robotics ETF
ARKW
ARK Next Generation Internet ETF
FWD
AB Disruptors ETF
ARKG
ARK Genomic Revolution ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement